View More Recent Stories

Jan 17, 2019 07:30AM ProMIS Neurosciences to Participate in NobleCon15 and CanTech Investment Conferences
Dec 18, 2018 07:30AM ProMIS Neurosciences to Present at Sachs Associates Neuroscience Innovation Forum and China Focus@JPMWeek
Nov 20, 2018 07:30AM ProMIS Neurosciences Issues Year-to Date Update, Highlighting 2018 Accomplishments
Nov 6, 2018 07:30AM ProMIS Neurosciences Discusses Critical Importance of Selectively Targeting the Root Cause of Alzheimer's Disease
Oct 11, 2018 07:30AM ProMIS Neurosciences Identifies Novel Antibody Drug Candidates for Parkinson's Disease
Sep 17, 2018 07:30AM ProMIS Neurosciences to Present at Extraordinary Futures Investment Conference
Aug 22, 2018 07:30AM ProMIS Neurosciences to Present at 20th Annual Global Investment Conference
Jul 10, 2018 07:30AM ProMIS Neurosciences to Present Preclinical Data on Alzheimer's Disease Therapeutic Antibody PMN310 at Alzheimer's Association International Conference
Jun 26, 2018 07:30AM ProMIS Neurosciences Unique Discovery Platform Generates Potential New Antibody Therapeutics for Neurodegenerative Diseases
Jun 20, 2018 07:30AM ProMIS Neurosciences Reminds Shareholders of June 25th Voting Cut-Off for Upcoming Annual General Meeting
May 1, 2018 07:30AM ProMIS Neurosciences Closes $7.2 Million Private Placement
Jan 25, 2018 07:30AM ProMIS Neurosciences Issues White Paper Entitled: "Not All Amyloid Beta Therapeutics Are Created Equal"
Dec 4, 2017 07:30AM ProMIS Neurosciences Announces Trading on OTCQB Venture Market
View More Recent Stories